Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $382 Million. The most recent transaction as insider was on May 18, 2021, when has been sold 22,000 shares (Common Stock) at a price of $2.33 per share, resulting in proceeds of $51,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M
0% 3M change
0% 12M change
Total Value Held $382 Million

ARMISTICE CAPITAL, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2021
BUY
Open market or private purchase
$51,260 $2.33 p/Share
22,000 Added 0.06%
39,100,000 Common Stock
May 17 2021
BUY
Open market or private purchase
$66,000 $2.2 p/Share
30,000 Added 0.08%
39,078,000 Common Stock
May 14 2021
BUY
Open market or private purchase
$275,200 $2.15 p/Share
128,000 Added 0.33%
39,048,000 Common Stock
Apr 15 2021
BUY
Conversion of derivative security
$12,571,430 $2.0 p/Share
6,285,715 Added 13.9%
38,920,000 Common Stock
Jan 08 2021
BUY
Open market or private purchase
$6,500,000 $2.6 p/Share
2,500,000 Added 7.12%
32,634,285 Common Stock
Dec 03 2020
BUY
Open market or private purchase
$48,800 $2.44 p/Share
20,000 Added 0.07%
30,134,285 Common Stock
Nov 25 2020
BUY
Open market or private purchase
$35,850 $2.39 p/Share
15,000 Added 0.05%
30,114,285 Common Stock
Nov 24 2020
BUY
Open market or private purchase
$114,559 $2.4 p/Share
47,733 Added 0.16%
30,099,285 Common Stock
Nov 23 2020
BUY
Open market or private purchase
$86,459 $2.32 p/Share
37,267 Added 0.12%
30,051,552 Common Stock
Sep 04 2020
BUY
Open market or private purchase
$220,000 $2.2 p/Share
100,000 Added 0.33%
30,014,285 Common Stock
Jun 09 2020
BUY
Open market or private purchase
$4,384,200 $2.5 p/Share
1,753,680 Added 5.54%
29,914,285 Common Stock
Mar 17 2020
BUY
Open market or private purchase
$3,999,999 $2.05 p/Share
1,951,219 Added 6.48%
28,160,605 Common Stock
Mar 16 2020
SELL
Other acquisition or disposition
-
3,455,129 Reduced 11.65%
26,209,386 Common Stock
Feb 03 2020
BUY
Open market or private purchase
$3,905,502 $3.98 p/Share
981,282 Added 3.2%
29,664,515 Common Stock
Jan 24 2020
BUY
Conversion of derivative security
-
3,000,000 Added 9.47%
28,683,233 Common Stock
Jan 22 2020
BUY
Conversion of derivative security
-
5,000,000 Added 16.3%
25,683,233 Common Stock
Sep 06 2019
BUY
Open market or private purchase
$2,950,000 $2.95 p/Share
1,000,000 Added 4.61%
20,683,233 Common Stock
Sep 04 2019
BUY
Open market or private purchase
$3,756,000 $3.13 p/Share
1,200,000 Added 5.75%
19,683,233 Common Stock
Aug 30 2019
BUY
Open market or private purchase
$79,429 $3.23 p/Share
24,591 Added 0.13%
18,483,233 Common Stock
Aug 29 2019
BUY
Open market or private purchase
$55,125 $3.21 p/Share
17,173 Added 0.09%
18,458,642 Common Stock
Aug 19 2019
BUY
Open market or private purchase
$8,204 $3.57 p/Share
2,298 Added 0.01%
18,441,469 Common Stock
Aug 16 2019
BUY
Open market or private purchase
$33,909 $3.43 p/Share
9,886 Added 0.05%
18,439,171 Common Stock
Aug 14 2019
BUY
Open market or private purchase
$191,558 $3.37 p/Share
56,842 Added 12.44%
400,000 Common Stock
Jun 05 2019
BUY
Open market or private purchase
$24,850 $4.97 p/Share
5,000 Added 0.03%
18,429,285 Common Stock
Jun 03 2019
BUY
Open market or private purchase
$47,300 $4.73 p/Share
10,000 Added 0.05%
18,424,285 Common Stock

Also insider at

BBI
Brickell Biotech, Inc. Healthcare
ALIM
ALIMERA SCIENCES INC Healthcare
KPRX
KIORA PHARMACEUTICALS INC Healthcare
SAVA
CASSAVA SCIENCES INC Healthcare
DFRG
Del Frisco's Restaurant Group, Inc.
VLRX
Valeritas Holdings Inc.
BPTH
BIO-PATH HOLDINGS INC Healthcare
AYTU
AYTU BIOPHARMA, INC Healthcare
ACHV
ACHIEVE LIFE SCIENCES, INC. Healthcare
AMAG
AMAG PHARMACEUTICALS, INC.
RSLS
ReShape Weightloss Inc.
INNV
INNOVUS PHARMACEUTICALS, INC.
ONTX
Onconova Therapeutics, Inc. Healthcare
VXRT
Vaxart, Inc. Healthcare
TTPH
TETRAPHASE PHARMACEUTICALS INC
TENX
TENAX THERAPEUTICS, INC. Healthcare
CYTH
Cyclo Therapeutics, Inc. Healthcare
RSLS
ReShape Lifesciences Inc. Healthcare
ACL

Armistice Capital, LLC

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Track Activities on AVTX